Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dapagliflozin in Cirrhotic Chronic Liver Disease Patients
NCT07684326Phase 3Recruiting
- Sponsor
- Beni Suef University
- Start
- Jul 2026
- Primary completion
- Jul 2027
- Countries
- 1
01
Overview
A Phase 3 trial of dapagliflozin in Liver cirrhosis (LC), ascites, sponsored by Beni Suef University. Started Jul 2026; status: recruiting.
02
Drugs
dapagliflozin
03
Conditions
Liver cirrhosis (LC)ascites
Beyond the preview
Go deeper on NCT07684326.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07684326.